rs2233851

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001025603.2(RFX5):​c.590G>A​(p.Arg197Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0101 in 1,614,078 control chromosomes in the GnomAD database, including 88 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0085 ( 2 hom., cov: 32)
Exomes 𝑓: 0.010 ( 86 hom. )

Consequence

RFX5
NM_001025603.2 missense

Scores

1
5
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 3.63
Variant links:
Genes affected
RFX5 (HGNC:9986): (regulatory factor X5) A lack of MHC-II expression results in a severe immunodeficiency syndrome called MHC-II deficiency, or the bare lymphocyte syndrome (BLS; MIM 209920). At least 4 complementation groups have been identified in B-cell lines established from patients with BLS. The molecular defects in complementation groups B, C, and D all lead to a deficiency in RFX, a nuclear protein complex that binds to the X box of MHC-II promoters. The lack of RFX binding activity in complementation group C results from mutations in the RFX5 gene encoding the 75-kD subunit of RFX (Steimle et al., 1995). RFX5 is the fifth member of the growing family of DNA-binding proteins sharing a novel and highly characteristic DNA-binding domain called the RFX motif. Multiple alternatively spliced transcript variants have been found but the full-length natures of only two have been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004905492).
BP6
Variant 1-151343848-C-T is Benign according to our data. Variant chr1-151343848-C-T is described in ClinVar as [Benign]. Clinvar id is 292617.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-151343848-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0085 (1294/152308) while in subpopulation AMR AF= 0.0158 (241/15300). AF 95% confidence interval is 0.0141. There are 2 homozygotes in gnomad4. There are 608 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RFX5NM_001025603.2 linkuse as main transcriptc.590G>A p.Arg197Gln missense_variant 9/11 ENST00000452671.7 NP_001020774.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RFX5ENST00000452671.7 linkuse as main transcriptc.590G>A p.Arg197Gln missense_variant 9/111 NM_001025603.2 ENSP00000389130 P1P48382-1

Frequencies

GnomAD3 genomes
AF:
0.00852
AC:
1296
AN:
152190
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00208
Gnomad AMI
AF:
0.00987
Gnomad AMR
AF:
0.0158
Gnomad ASJ
AF:
0.00893
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.00594
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0121
Gnomad OTH
AF:
0.0181
GnomAD3 exomes
AF:
0.00886
AC:
2224
AN:
251136
Hom.:
15
AF XY:
0.00901
AC XY:
1223
AN XY:
135786
show subpopulations
Gnomad AFR exome
AF:
0.00173
Gnomad AMR exome
AF:
0.0116
Gnomad ASJ exome
AF:
0.00984
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00180
Gnomad FIN exome
AF:
0.00651
Gnomad NFE exome
AF:
0.0125
Gnomad OTH exome
AF:
0.0126
GnomAD4 exome
AF:
0.0102
AC:
14976
AN:
1461770
Hom.:
86
Cov.:
37
AF XY:
0.0101
AC XY:
7368
AN XY:
727174
show subpopulations
Gnomad4 AFR exome
AF:
0.00266
Gnomad4 AMR exome
AF:
0.0124
Gnomad4 ASJ exome
AF:
0.00918
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00155
Gnomad4 FIN exome
AF:
0.00818
Gnomad4 NFE exome
AF:
0.0115
Gnomad4 OTH exome
AF:
0.0107
GnomAD4 genome
AF:
0.00850
AC:
1294
AN:
152308
Hom.:
2
Cov.:
32
AF XY:
0.00816
AC XY:
608
AN XY:
74472
show subpopulations
Gnomad4 AFR
AF:
0.00207
Gnomad4 AMR
AF:
0.0158
Gnomad4 ASJ
AF:
0.00893
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.000621
Gnomad4 FIN
AF:
0.00594
Gnomad4 NFE
AF:
0.0120
Gnomad4 OTH
AF:
0.0180
Alfa
AF:
0.0132
Hom.:
39
Bravo
AF:
0.00947
TwinsUK
AF:
0.0132
AC:
49
ALSPAC
AF:
0.0127
AC:
49
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.0126
AC:
108
ExAC
AF:
0.00877
AC:
1065
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.0143
EpiControl
AF:
0.0161

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

MHC class II deficiency Benign:3
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
not specified Benign:2
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2023RFX5: BS1, BS2 -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
RFX5-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 02, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.38
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.078
T;T;.;T;T;T
Eigen
Uncertain
0.21
Eigen_PC
Uncertain
0.27
FATHMM_MKL
Benign
0.66
D
LIST_S2
Uncertain
0.89
.;.;D;D;D;D
MetaRNN
Benign
0.0049
T;T;T;T;T;T
MetaSVM
Benign
-0.74
T
MutationAssessor
Uncertain
2.5
M;M;.;M;.;.
MutationTaster
Benign
0.60
D;D;D;D
PrimateAI
Uncertain
0.57
T
PROVEAN
Benign
0.29
N;N;N;N;N;N
REVEL
Benign
0.091
Sift
Benign
0.082
T;T;T;T;T;T
Sift4G
Benign
0.084
T;T;T;T;.;.
Polyphen
0.99
D;D;.;D;.;.
Vest4
0.096
MVP
0.79
MPC
0.59
ClinPred
0.029
T
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.038
gMVP
0.24

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2233851; hg19: chr1-151316324; API